"Boehringer Ingelheim believed in my idea and supported me, which is what got the research going. That made a lasting impression on me."

Madiha Derouaz , AMAL Therapeutics

We realize scientific opportunities by embracing the power of partnership and collaborating with a diverse group of experts across the life-science community including third party institutions, pharmaceutical specialists and external customers. We champion new, radical ways to work with others beyond our walls. For example, by investing in our open innovation platform, ‘OpnMe’, we can quickly gather the best thinking from around the world. We set research challenges, invite proposals, identify new indications and even kickstart stalled molecular research via the platform.